Futu News reported on May 28 that all three major indices of Hong Kong stocks were adjusted. At the close, the Hang Seng Index fell 0.03%, the Science Index fell 0.26%, and the China Index fell 0.03%.
By the close, Hong Kong stocks were up 822, down 1,099, and closed at 1,093.
The specific industry performance is as follows:
On the sector side, the trend of TechNet shares was mixed. Xiaomi fell nearly 2%, Bilibili fell more than 1%, JD, Baidu, and Kuaishou fell slightly; Tencent rose nearly 1%, while NetEase, Meituan, and Ali rose slightly.
Internet medical stocks rose; Ali Health rose more than 10%, Ping An Good Doctor rose more than 3%, and Jingdong Health rose more than 2%.
Coal stocks rose. Mongolian coking coal rose nearly 5%, Yancoal and Australia rose nearly 4%, Shougang resources rose nearly 3%, China Shenhua rose more than 2%, China Coal Energy rose more than 2%, and Yankuang Energy rose more than 1%.
Shipping port stocks strengthened, with Orient Overseas International up more than 4%, COSCO Marine Holdings up more than 3%, and COSCO Marine Energy up more than 2%.
Petroleum stocks rose sharply; CNPC shares rose more than 2%, and CNOOC and Kunlun Energy rose nearly 1%.
Apple concept stocks generally rose. BYD Electronics rose more than 2%, Ruisheng Technology rose nearly 2%, Gaowei Electronics rose more than 1%, and Shunyu Optical Technology rose slightly.
A number of film and television stocks rose. Starry Sky Chinese rose nearly 29%, Maogan Entertainment rose more than 2%, and Alibaba Pictures rose more than 1%.
On the other side, steel stocks and Hao Gaming stocks generally rose; the decline in heavy machinery stocks widened at the end of the session, and domestic housing stocks showed a high opening and low trend.
In terms of individual stocks,$ALI HEALTH (00241.HK)$It rose more than 10%, and adjusted net profit for the 2024 fiscal year increased by about 90% year on year.
$FIT HON TENG (06088.HK)$With an increase of more than 8%, the TWS business is expected to start increasing in the second half of the year, and full-year revenue may achieve double-digit growth.
$REMEGEN (09995.HK)$It increased by more than 5%, and many excellent data such as ovarian cancer, NSCLC, and cervical cancer were revealed for the first time.
$PRODUCTIVE TECH (00650.HK)$With a rise of nearly 11%, the third phase of the Big Fund has been launched, and the progress of domestic semiconductor production is expected to accelerate further.
$OOIL (00316.HK)$It rose more than 4%, and SCFI hit a 21-month high for seven weeks.
Today's top 10 Hong Kong stock turnover
Hong Kong Stock Connect Capital
On the Hong Kong Stock Connect side, today's net inflow of Hong Kong Stock Connect (southbound) was HK$4.166 billion.
Agency Perspectives
Xiaomo: Maintaining NetEase's “Gain” rating with a target price of HK$200
J.P. Morgan Chase released a research report saying that it will maintain$NTES-S (09999.HK)$The “Overweight” rating is the first choice for the mainland online game industry. The target price is HK$200. According to the report, regarding the recent adjustment of monetization models for some large-scale multiplayer online role-playing games, such as “Journey to the West,” the conclusion reached during discussions with NetEase management was that there would be little impact in the short term, and that this strategic change should support the long-term healthy growth of these games.
Tama: To give Chow Tai ?$#@$ a “in sync with the market” rating, the target price was reduced to HK$12
Morgan Stanley released a research report saying,$CHOW TAI FOOK (01929.HK)$“In line with the market” rating, in view of the sharp rise in gold prices in the second half of the 2024 fiscal year, especially in March, it is estimated that Chow Tai Fook's gold loan will experience huge unrealized losses in the second half of the fiscal year. It is estimated that the annual net profit will increase by 31%, and the dividend per share is expected to reach 0.6 yuan, which means that the dividend ratio is 85%, and the target price will drop from HK$13.5 to HK$12.
Bank of America Securities: Maintaining Ali Health's “Buy” Rating, Target Price HK$4.5
Bank of America Securities released a research report stating that it will maintain$ALI HEALTH (00241.HK)$A “buy” rating, with a target price of HK$4.5, and is expected to show good business momentum in the 2025 fiscal year. It is expected that revenue will resume positive growth, profit growth will accelerate, and benefit from the integration of newly acquired high-profit marketing businesses.
Edit/Cynthia